623
Participants
Start Date
March 28, 2019
Primary Completion Date
June 11, 2020
Study Completion Date
June 11, 2020
Tavilermide ophthalmic solution
BID topical dosing
Placebo
BID topical dosing
Tavilermide Investigational Site, Shelby
Tavilermide Investigational Site, Coral Springs
Tavilermide Investigational Site, Boynton Beach
Tavilermide Investigational Site, Bradenton
Tavilermide Investigational Site, Ocala
Tavilermide Investigational Site, Nashville
Tavilermide Investigational Site, Maryville
Tavilermide Investigational Site, Louisville
Tavilermide Investigational Site, Lexington
Tavilermide Investigational Site, Mason
Tavilermide Investigational Site, Cincinnati
Tavilermide Investigational Site, Indianapolis
Tavilermide Investigational Site, Sioux City
Tavilermide Investigational Site, Kenosha
Tavilermide Investigational Site, Rapid City
Tavilermide Investigational Site, St Louis
Tavilermide Investigational Site, San Antonio
Tavilermide Investigational Site, Littleton
Tavilermide Investigational Site, Fort Collins
Tavilermide Investigational Site, Phoenix
Tavilermide Investigational Site, Los Angeles
Tavilermide Investigational Site, Newport Beach
Lead Sponsor
Mimetogen Pharmaceuticals USA, Inc.
INDUSTRY